Leonard S. Schleifer

2016

In 2016, Leonard S. Schleifer earned a total compensation of $28.3M as President and Chief Executive Officer at Regeneron Pharmaceuticals, a 40% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$2,235,600
Option Awards$24,631,012
Salary$1,242,000
Other$228,908
Total$28,337,520

Schleifer received $24.6M in option awards, accounting for 86.92% of the total pay in 2016.

Schleifer also received $2.2M in non-equity incentive plan, $1.2M in salary and $228.9K in other compensation.

Overall ranking

Ranking

50

out of 14,053
Percentile100th

Leonard S. Schleifer's 2016 compensation ranked 50th out of 14,053 executive pay records tracked by us this year.

Schleifer earned more than 99.6% of all executives tracked by us in 2016.

Ranking in industry group

Industry groupDrugs
Ranking

4

out of 1,505
Percentile100th

In the industry group of Drugs, Schleifer's pay ranked 4th out of 1,505 executive pay records tracked by us in 2016.

Schleifer earned more than 99.7% of executives in this group.

Source: SEC filing on April 26, 2019.

Schleifer's colleagues

We found two more compensation records of executives who worked with Leonard S. Schleifer at Regeneron Pharmaceuticals in 2016.

2016

George Yancopoulos

Regeneron Pharmaceuticals

Chief Scientific Officer

2016

Robert Landry

Regeneron Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like